The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension.
about
A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?Lack of bcr and abr promotes hypoxia-induced pulmonary hypertension in miceChanges in large pulmonary arterial viscoelasticity in chronic pulmonary hypertensionA brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironmentApelin and pulmonary hypertension.Reck enables cerebrovascular development by promoting canonical Wnt signaling.4,4'-Methylenedianiline Alters Serotonergic Transport in a Novel, Sex-Specific Model of Pulmonary Arterial Hypertension in Rats.Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.Involvement of B-cell CLL/lymphoma 2 promoter methylation in cigarette smoke extract-induced emphysema.Signal transduction in the development of pulmonary arterial hypertensionCharacterization of early neovascular response to acute lung ischemia using simultaneous (19)F/ (1)H MR molecular imaging.The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models.Animal Models of Pulmonary Hypertension: Matching Disease Mechanisms to Etiology of the Human Disease.The first Keystone Symposia Conference on pulmonary vascular isease and right ventricular dysfunction: Current concepts and future therapies.New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis.A novel murine model of severe pulmonary arterial hypertension.[Aberrant reparative tissue remodeling: histopathology and molecular pathology].Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.Treatment with anti-gremlin 1 antibody ameliorates chronic hypoxia/SU5416-induced pulmonary arterial hypertension in mice.Systemic vasoconstriction modulates the responses of pulmonary vasculature and airway to vasoconstrictors in anesthetized rats.Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery.Metal Compounds as Kinase and Phosphatase Inhibitors in Drug Development: The Role of the Metal and Ligands
P2860
Q27026643-A0FFD6C7-A4F9-4295-BF8D-854C595D07ADQ28512646-7AB29E82-053B-472A-860C-000C766C37F0Q28534877-93F4EBD9-22C7-46E5-8262-268A56B47F0BQ30544892-F9699839-0B75-4186-8E9B-6BC7DF7DC367Q33942620-395397EB-7939-40BC-A09E-11CEAA22F033Q35573931-1E13DC66-1BE7-4659-98BE-A7B8E47497F7Q36497231-BE82AED4-D1D0-4DBF-A871-24523C528D0AQ36515926-49C6A00A-1BF8-4F9C-A4E1-CFFE56C1B8FFQ36549041-1DFFF8FA-AAFC-4AD2-BFB1-4E456057A9AFQ36755620-87502697-BF32-4CE0-A9C4-03975606ACF8Q37107240-1B167B9D-0DF2-4BD8-B868-2F9C866594ABQ37133785-AD8E6045-5A6F-49A9-A48E-AE7C3D18A9FBQ37626285-9785AD89-B6D1-461C-8DD4-D050F97A4EA3Q38102555-77E9759B-11B7-430B-821F-06B487E02765Q38364225-CFBBEDE2-2375-4F69-8A88-06C411546C08Q39353707-5530A4A2-E855-4E68-B762-72F73C28BDEFQ41853468-9A8513B9-48A2-4B98-9CA1-BA867FC817E5Q43409467-6A117D9D-E77D-4B2C-AA72-43CA7D3C56E8Q44835646-04DF86EC-67D3-4D44-BCF4-CB8F58207927Q45030673-E3A88F91-399D-4190-924C-E9DAC2A3FA40Q45401428-648B6E96-159E-442B-B426-7AC70FBEE387Q51614967-81B5224D-6E63-443A-B683-81B119F0FAFAQ51741338-ACD90643-43B4-4150-8CC3-4FA3D5647708Q57693525-91F070C5-8D15-4D60-A549-5161BFA18837
P2860
The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
The effects of antiangiogenic ...... lmonary arterial hypertension.
@en
The effects of antiangiogenic ...... lmonary arterial hypertension.
@nl
type
label
The effects of antiangiogenic ...... lmonary arterial hypertension.
@en
The effects of antiangiogenic ...... lmonary arterial hypertension.
@nl
prefLabel
The effects of antiangiogenic ...... lmonary arterial hypertension.
@en
The effects of antiangiogenic ...... lmonary arterial hypertension.
@nl
P2860
P356
P1433
P1476
The effects of antiangiogenic ...... lmonary arterial hypertension.
@en
P2093
Koichiro Tatsumi
Seiichiro Sakao
P2860
P304
P356
10.1159/000322011
P577
2010-11-30T00:00:00Z